These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19575764)

  • 21. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study.
    Ong TZ; Hawkey CJ; Ho KY
    J Clin Gastroenterol; 2006 Oct; 40(9):795-800. PubMed ID: 17016134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandins: an overview of the worldwide clinical experience.
    Dajani EZ; Wilson DE; Agrawal NM
    J Assoc Acad Minor Phys; 1991; 2(1):23, 27-35. PubMed ID: 1811816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK
    J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NSAID, ulcers, and prostaglandins.
    Kimmey MB
    J Rheumatol Suppl; 1992 Nov; 36():68-73. PubMed ID: 1474538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for gastrointestinal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).
    Agrawal N
    J Fam Pract; 1991 Jun; 32(6):619-24. PubMed ID: 2040888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
    Laine L
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inadequate prevention of NSAID-induced gastrointestinal events.
    Herings RM; Goettsch WG
    Ann Pharmacother; 2004 May; 38(5):760-3. PubMed ID: 15031416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology and risk factors of gastroduodenal ulcer].
    Kreiss C; Blum AL
    Chirurg; 1996 Jan; 67(1):7-13. PubMed ID: 8851669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacology of preventive and therapeutic drugs for NSAIDs ulcers in the gastrointestinal tract].
    Naito Y; Takagi T; Yoshikawa T
    Nihon Rinsho; 2011 Jun; 69(6):1007-15. PubMed ID: 21688620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A genetic background of ulcer diseases induced by NSAID/aspirin].
    Arisawa T; Tahara T; Nakamura M
    Nihon Rinsho; 2010 Nov; 68(11):2113-8. PubMed ID: 21061542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The choice of selective COX-2 inhibitors].
    Hiratsuka T; Sakamoto C
    Nihon Rinsho; 2007 Oct; 65(10):1819-23. PubMed ID: 17926530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current issues of NSAID-induced gastrointestinal ulcer in Japan].
    Sugano K
    Nihon Rinsho; 2007 Oct; 65(10):1754-8. PubMed ID: 17926520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenesis of NSAIDs-induced gastrointestinal ulcers].
    Yoshikawa T; Naito Y
    Nihon Rinsho; 2011 Jun; 69(6):995-1002. PubMed ID: 21688618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [NSAIDs induced gastroduodenal ulcer in the aged].
    Asaki S
    Nihon Rinsho; 2002 Aug; 60(8):1527-32. PubMed ID: 12187746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsteroidal anti-inflammatory drugs and gastrointestinal disease: pathophysiology, treatment and prevention.
    Bjorkman DJ; Kimmey MB
    Dig Dis; 1995; 13(2):119-29. PubMed ID: 7586632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.